HCA Previews 2017 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
HCA Holdings (HCA) PT Lowered to $90 at Jefferies Following 3Q Pre-Announcement
October 19, 2017 8:48 AM EDTJefferies lowered its price target on HCA Holdings (NYSE: HCA) to $90.00 (from $92.00) while maintaining a Buy rating following the company's 3Q pre-announcement. HCA pre-announced Q3 EBITDA of $1.776B vs. $1.97B consensus. EBITDA was dragged down by the hurricanes ($140MM) and a TX Medicaid... More
